Rocket Pharmaceuticals Inc header image

Rocket Pharmaceuticals Inc

RCKT

Equity

ISIN null / Valor 39764376

NASDAQ (2026-08-06)

USD 3.54+1.14%

Rocket Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rocket Pharmaceuticals Inc. is a New York–based, Nasdaq‑listed clinical‑stage biotechnology company developing gene therapies for rare, inherited pediatric diseases. The firm advances both ex vivo lentiviral approaches—principally via genetically modified hematopoietic stem cells—and in vivo AAV‑based therapies, with clinical programs targeting hematologic, neuromuscular and cardiac genetic disorders. In addition to advancing multiple clinical candidates, Rocket operates internal vector manufacturing and development capabilities to support its trials and regulatory filings, positioning itself as a developer of durable, one‑time genetic interventions for severe monogenic conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

17.2%1Y

-79.7%3Y

-89.8%5Y

Performance

73.9%1Y

91.0%3Y

85.1%5Y

Volatility

387 M

Market cap (USD)

2,119,567

Daily traded volume (Shares)

12.25 / 11.56

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

4.00

Society:

2.00

Nature:

2.00

Pascale Gonzalez

Switzerland, 16 Apr 2025

So la la

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

0.99%USD 82.80

Alkem Laboratories Ltd.

Alkem Laboratories Ltd. Valor: 30689895

Annual Return

-50%0%+50%

Risk level

110

-0.96%INR 5,608.45

Insmed Inc

Insmed Inc Valor: 12614415

Annual Return

-50%0%+50%

Risk level

110

33.86%USD 132.55

Laurus Labs Ltd.

Laurus Labs Ltd. Valor: 56464789

Annual Return

-50%0%+50%

Risk level

110

-0.36%INR 1,836.00

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

2.27%INR 834.60

Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Ltd. Valor: 30795490

Annual Return

-50%0%+50%

Risk level

110

-0.98%INR 1,883.80

Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. Valor: 11536062

Annual Return

-50%0%+50%

Risk level

110

-2.76%INR 562.55

Cohance Lifesciences Ltd

Cohance Lifesciences Ltd Valor: 46346459

Annual Return

-50%0%+50%

Risk level

110

2.54%INR 439.85

Gland Pharma Ltd.

Gland Pharma Ltd. Valor: 56038514

Annual Return

-50%0%+50%

Risk level

110

2.82%INR 2,617.50

MEDICLIN AG

MEDICLIN AG Valor: 1158721

Annual Return

-50%0%+50%

Risk level

110

-2.31%EUR 4.22

SIX

FactSet

Clearbit

Logos provided by Clearbit